Publications

Authors:

Speranza, Desirèe; Sapuppo, Elena; Aprile, Giuseppe; Auriemma, Alessandra; Bergamo, Francesca; Bianco, Roberto; Bordonaro, Roberto; Brandi, Giovanni; Brunetti, Oronzo; Carnaghi, Carlo; Ciliberto, Domenico; Cinieri, Saverio; Corallo, Salvatore; De Vita, Ferdinando; Di Donato, Samantha; Ferraù, Francesco; Fornaro, Lorenzo; Barucca, Viola; Giommoni, Elisa; Lotesoriere, Claudio; Luchini, Claudio; Masini, Cristina; Niger, Monica; Pisconti, Salvatore; Rapposelli, Ilario Giovanni; Rimassa, Lorenza; Rognone, Chiara; Rodriquenz, Maria Grazia; Corsini, Lidia Rita; Santin, Daniele; Scarpa, Aldo; Scartozzi, Mario; Soto Parra, Hector; Tonini, Giuseppe; Tortora, Giampaolo; Tralongo, Paolo; Silvestris, Nicola

Title:

The Italian Rare Biliary tract Cancer initiative (IRaBiCa): A multicentric observational study of Gruppo Oncologico dell'Italia Meridionale (GOIM) in collaboration with Gruppo Italiano Colangiocarcinoma (GICO)

Year:

2024

Type of item:

Articolo in Rivista

Tipologia ANVUR:

Articolo su rivista

Language:

Inglese

Referee:

No

Name of journal:

Tumori

ISSN of journal:

0300-8916

N° Volume:

110

Number or Folder:

3

Page numbers:

203-208

Keyword:

Rare tumors; biliary tract cancer; rare histotypes

Short description of contents:

Introduction: About 90% of cholangiocarcinomas are adenocarcinomas with glandular or tubular structures lined by epithelial cells, with no bile production and with a variable degree of differentiation, arising in the background of desmoplastic stroma. The remaining 10% is represented by rarer histological variants of which there is little knowledge regarding the biological behavior, molecular characterization, and sensitivity to the various possible therapies, including molecular-based treatments. Such rare tumors are described only in case reports or small retrospective series because of their exclusion from clinical trials. This national initiative, here presented, aims to address the following knowledge gap: a) how much does histological diversity translate into clinical manifestation variety? b) are those chemotherapy regimens, recommended for conventional biliary tract cancers, potentially active in rare variants?Therefore, epidemiological, pathological, and clinical characterization of series of rare biliary histotypes/variants, for which therapeutic and follow-up data are available, will be collected. Methods: An Italian task force on rare tumors of the biliary tract (IRaBiCa) has been created, whose initiative is a multicenter retrospective study involving 34 Italian cancer centers.Clinical data from approximately 100 patients will be collected and analyzed. Continuous variables will be presented as median ± standard deviation, while categorical variables will be expressed in terms of frequency. Kaplan-Maier analyses will be used to compare disease free, progression free and overall survival, according to the different histotypes. Conclusions: We expect to gather novel data on rare histotypes of biliary tract cancer that will be useful to support their molecular and immunological characterization.

Note:

Epub 2024 Feb 7

Product ID:

137593

Handle IRIS:

11562/1118887

Last Modified:

June 9, 2024

Bibliographic citation:

Speranza, Desirèe; Sapuppo, Elena; Aprile, Giuseppe; Auriemma, Alessandra; Bergamo, Francesca; Bianco, Roberto; Bordonaro, Roberto; Brandi, Giovanni; Brunetti, Oronzo; Carnaghi, Carlo; Ciliberto, Domenico; Cinieri, Saverio; Corallo, Salvatore; De Vita, Ferdinando; Di Donato, Samantha; Ferraù, Francesco; Fornaro, Lorenzo; Barucca, Viola; Giommoni, Elisa; Lotesoriere, Claudio; Luchini, Claudio; Masini, Cristina; Niger, Monica; Pisconti, Salvatore; Rapposelli, Ilario Giovanni; Rimassa, Lorenza; Rognone, Chiara; Rodriquenz, Maria Grazia; Corsini, Lidia Rita; Santin, Daniele; Scarpa, Aldo; Scartozzi, Mario; Soto Parra, Hector; Tonini, Giuseppe; Tortora, Giampaolo; Tralongo, Paolo; Silvestris, Nicola, The Italian Rare Biliary tract Cancer initiative (IRaBiCa): A multicentric observational study of Gruppo Oncologico dell'Italia Meridionale (GOIM) in collaboration with Gruppo Italiano Colangiocarcinoma (GICO) «Tumori» , vol. 110 , n. 3 , 2024 , pp. 203-208

Consulta la scheda completa presente nel repository istituzionale della Ricerca di Ateneo